Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
40°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
790.39
+53.19 (+7.22%)
Streaming Delayed Price
Updated: 10:12 AM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
75
76
Next >
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month
February 08, 2024
Investors are still excited about obesity treatments and weight-management drugs.
Via
The Motley Fool
S&P 500 Hits 5,000 Milestone, Yet Concerns Of Overvaluation Versus Its Equal-Weight Counterpart Mount
February 08, 2024
S&P 500 index at 5,000 points; caution signals emerge in comparison to equal-weight index. Magnificent Seven heavyweights contribute 64% of returns.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The 3 Most Undervalued Biotech Stocks to Buy in February 2024
February 08, 2024
With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider.
Via
InvestorPlace
Why Foghorn Therapeutics (FHTX) Stock Is Exploding Higher
February 08, 2024
Foghorn Therapeutics shares are trading higher by 44.8% Thursday. The company announced that Eli Lilly has chosen FHD-909 for clinical development.
Via
Benzinga
4 Reasons Why 2024 Could Be Eli Lilly's Worst Year for the Rest of This Decade
February 08, 2024
Lilly's headwinds in 2024 should only be temporary challenges.
Via
The Motley Fool
LLY Vs NVO: Which One Is Likely To Become A $1T Company First
February 08, 2024
Tackling growing waistlines is expected to yield much shareholder value.
Via
Talk Markets
Market Whales and Their Recent Bets on LLY Options
February 07, 2024
Via
Benzinga
Earnings Scheduled For February 6, 2024
February 06, 2024
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.
Via
Benzinga
Viking Therapeutics Charges To A Record High On An Update For Its Eli Lilly-Rivaling Obesity Drug
February 08, 2024
The company is looking to take on Eli Lilly's tirzepatide as both a shot and a pill for weight loss.
Via
Investor's Business Daily
What's Going On Eli Lilly Stock Thursday?
February 08, 2024
Eli Lilly's impressive stock surge, better-than-expected Q4 results, and positive analyst reviews.
Via
Benzinga
The Skinny On Novo Nordisk: Weight-Loss Meds Make Big Pharma A Big Foe For Food Industry
February 08, 2024
Novo Nordisk's groundbreaking weight-loss treatments are causing concern in the food industry. CEOs are seeking advice from the company.
Via
Benzinga
SPDR ETF Report For Wednesday, February 7
February 08, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day just ended, Wednesday, February 7
Via
Talk Markets
Topics
ETFs
Apple, Chipotle And Eli Lilly Stocks Baffle Jim Cramer With Unusual Moves: 'Authentic Stupidity Is A Perfectly Plausible Explanation'
February 07, 2024
Cramer questioned the rationale behind the market's behavior, emphasizing that not all stock movements are logical, especially during earnings season.
Via
Benzinga
Triple Threat Of Key Reversals: Warning Shots Fired In 3 High Fliers
February 07, 2024
In a potential warning sign to investors, three high-flying stocks had key reversals on Tuesday. This means the stocks opened to new highs before trading below their previous closing price.
Via
Benzinga
Analysts Boost Eli Lilly's Forecast With High Hopes On Mounjaro, Zepbound Performance
February 07, 2024
Eli Lilly's SYNERGY-NASH Phase 2 study results and positive market outlook drive BMO's raised price target to $865. Morgan Stanley remains bullish on Mounjaro/Zepbound launch. BofA Securities cites...
Via
Benzinga
Abbott Laboratories Stock Getting Closer To Key Technical Benchmark
February 07, 2024
Abbott Laboratories shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
Via
Investor's Business Daily
SPDR ETF Report For Tuesday, February 6
February 07, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day just ended, Tuesday, February 6
Via
Talk Markets
Topics
ETFs
Eli Lilly (LLY) Q4 2023 Earnings Call Transcript
February 06, 2024
LLY earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition
February 06, 2024
Some of the best stocks to buy in February according to MarketMaster AI suggest that a major economic recovery is underway.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks
February 06, 2024
Thanks to weight loss and obesity drugs, Eli Lilly and Novo Nordisk could become the first trillion-dollar stocks in the pharma industry.
Via
InvestorPlace
Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?
February 06, 2024
At noon trading in New York, major equity indices on Wall Street remain directionless as traders evaluate the future course of monetary policy ahead of several speeches by Federal Reserve officials in...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Eli Lilly Stock Jumped as Much as 5.1% Today Then Gave Up Its Gains
February 06, 2024
Investors shouldn't worry that Lilly's gains quickly evaporated.
Via
The Motley Fool
Stocks In China Flying, Lifting Sentiment In Stock Markets Across The Globe, AI And Weight Loss Drugs Get Hotter
February 06, 2024
To gain an edge, this is what you need to know today.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Chips Vs. Oil: Nvidia Now Outweighs The S&P 500's Entire Energy Sector
February 06, 2024
Nvidia now has a market cap more than the combined value of the S&P 500 energy sector.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Dow Jumps Over 100 Points; Eli Lilly Posts Upbeat Earnings
February 06, 2024
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.34% to 38,509.84 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Eli Lilly Soars On Diabetes And Obesity Drug Boom, Projects 20% Revenue Increase In 2024
February 06, 2024
This surge is attributed to the popularity of Lilly's new diabetes drug, Mounjaro, and its anti-obesity medication, Zepbound.
Via
Benzinga
Investors Cheer Eli Lilly Earnings, Q4 Performance Surpasses Expectations Thanks To Strong Zepbound Launch, Surging Weight Loss Drug Sales
February 06, 2024
Eli Lilly beats Q4 2023 revenue expectations at $9.35 billion, driven by higher realized prices and strong sales of Mounjaro, Verzenio, and Jardiance.
Via
Benzinga
US Stocks Brace For Another Day In The Red As Rally Loses Steam: Analyst Sees Market Pullback On This Indicator
February 06, 2024
The stock rally that propelled the S&P 500 and the Dow to record highs last week seems to have stalled, with Fed officials remaining non-committal about rate-cut plans.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Eli Lilly Stock Veers Higher On Fourth-Quarter Beat
February 06, 2024
Eli Lilly Scored a strong Q4 win and provided healthy guidance Tuesday. Shares moved toward a profit-taking zone following a January breakout.
Via
Investor's Business Daily
Investor Sentiment Improves Following Services PMI; S&P 500 Slips From Record Levels
February 06, 2024
The CNN Money Fear and Greed index showed further improvement in overall market sentiment, but it remained in the "Greed" zone on Monday. U.S. stocks closed lower on Monday, with the S&P 500 index...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
75
76
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.